Description:
Ticagrelor is a platelet aggregation inhibitor and P2Y12 receptor antagonist. It has been used for the prevention of thrombotic events like stroke or heart attack in patients with acute coronary syndrome or myocardial infarction with ST elevation.
- Molecular Weight:522.57
- Purity:≥98%
Molecular Formula:
C23H28F2N6O4S
Canonical SMILES:
CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F
InChI:
InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1
InChIKey:
OEKWJQXRCDYSHL-FNOIDJSQSA-N
Appearance:
White to Off-white Solid
Synonyms:
Brilinta; Brilique; AZD-6140; AZD6140; AZD 6140; AR-C 126532XX; AR-C-126532XX; AR-C126532XX; Possia Weitere Informationen finden Sie
hier